Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Net Sales Growth(%) 1.98-5.8612.442.857.86

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 1.98 based on Mar2024 Consolidated results.
Year Net Sales Growth
Mar20241.98
Mar2023-5.86
Mar202212.44
Mar20212.85
Mar20207.86

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44
336.49
Mar2021 2.85
-63.74
Mar2020 7.86 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,810.4 Cr 3.7% 5% 40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

5%

40.9%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses